Literature DB >> 31324695

Role of endotoxemia in causing renal dysfunction in cirrhosis.

Jennifer L Peng1, Witina Techasatian1, Takashi Hato2, Suthat Liangpunsakul1,3.   

Abstract

Renal failure is a challenging problem in patients with cirrhosis since mortality increases with worsening renal function, hence the inclusion of serum creatinine in calculating the Model for End-Stage Liver Disease score for liver transplant evaluation. Among the various causes, infection is the leading etiology of mortality associated with cirrhosis. Bacterial infection frequently precipitates renal failure in patients with cirrhosis with the reported prevalence around 34%. Patients with cirrhosis are at increased risk of infections due to impaired immunity and increased gut permeability leading to bacterial translocation in the setting of portal hypertension. One of the most feared complications of severely decompensated liver and renal failure is hepatorenal syndrome, of which liver transplant may be the only available treatment. Furthermore, in those with spontaneous bacterial peritonitis and urinary tract infection, progressive renal failure occurs despite resolution of infection. Thus, the effects of endotoxemia on renal function in cirrhosis have become a major focus of research. The mechanisms of the damaging effects of endotoxin on renal function are complex but, in essence, involve dysregulated inflammation, circulatory dysfunction, poor clearance of endotoxin burden, as well as vasomotor nephropathy. In this article, we will review the mechanisms of endotoxemia-induced renal dysfunction in the setting of cirrhosis through the effects on renal blood flow, renal vascular endothelium, glomerular filtration rate, and tubular function. © American Federation for Medical Research 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  acute kidney injury; bacterial infections; liver cirrhosis

Year:  2019        PMID: 31324695     DOI: 10.1136/jim-2019-001056

Source DB:  PubMed          Journal:  J Investig Med        ISSN: 1081-5589            Impact factor:   2.895


  3 in total

1.  Intestinal SIRT1 Deficiency-Related Intestinal Inflammation and Dysbiosis Aggravate TNFα-Mediated Renal Dysfunction in Cirrhotic Ascitic Mice.

Authors:  Yu-Te Chou; Tze-Tze Liu; Ueng-Cheng Yang; Chia-Chang Huang; Chih-Wei Liu; Shiang-Fen Huang; Tzu-Hao Li; Hsuan-Miao Liu; Ming-Wei Lin; Ying-Ying Yang; Tzung-Yan Lee; Yi-Hsiang Huang; Ming-Chih Hou; Han-Chieh Lin
Journal:  Int J Mol Sci       Date:  2021-01-27       Impact factor: 5.923

2.  Pioglitazone Ameliorates Acute Endotoxemia-Induced Acute on Chronic Renal Dysfunction in Cirrhotic Ascitic Rats.

Authors:  Szu-Yu Liu; Chia-Chang Huang; Shiang-Fen Huang; Tsai-Ling Liao; Nai-Rong Kuo; Ying-Ying Yang; Tzu-Hao Li; Chih-Wei Liu; Ming-Chih Hou; Han-Chieh Lin
Journal:  Cells       Date:  2021-11-05       Impact factor: 6.600

3.  Case Report of Cardiorenal Syndrome with Ascites and Listeria monocytogenes Peritonitis: The Role of Large-Volume Paracentesis and Albumin Replacement.

Authors:  Minas Karagiannis; Panagiotis Giannakopoulos; Aggeliki Sardeli; Ourania Tsotsorou; Dimitra Bacharaki; Demetrios V Vlahakos
Journal:  Am J Case Rep       Date:  2022-02-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.